JPS56131516A - Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent - Google Patents
Immunochemotherapy, prevention of resistance to drug, and carcinostatic agentInfo
- Publication number
- JPS56131516A JPS56131516A JP3561780A JP3561780A JPS56131516A JP S56131516 A JPS56131516 A JP S56131516A JP 3561780 A JP3561780 A JP 3561780A JP 3561780 A JP3561780 A JP 3561780A JP S56131516 A JPS56131516 A JP S56131516A
- Authority
- JP
- Japan
- Prior art keywords
- resistance
- prevention
- drugs
- carcinostatic
- immunochemotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: An immunochemotherapy, prevention of resistance to drugs, and carcinostatic agent having extremely improved immunologically enhancing actions, comprising a specific hydroxyaniline derivative as an active ingredient.
CONSTITUTION: An immunochemotherpy, prevention of resistance to drugs, and carcinostatic agent comprising a compound shown by the formula (R1 is H; R2 is hydroxyalkyl or carboxyalkyl; R3 is H or lower alkoxy; R1 and R2 may be bonded to form a nitrogen-containing hetero ring) as an active ingredient. The compound has extremely improved immunologically enhancing effects and preventing effect of resistance to drugs by itself, and has synergistic effects by combined use with other carcinostatic agents, antibiotics, and vaccines. It can prevent the reduction of immunological competence resulting from continuous use of adrenocortical hormone or common carcinostatic agents, and bacteria turnover phenomena and turnover diseases caused by continuous administration of antibiotics. It is converted into pharmaceutical preparations, e.g., injection, oral drug, external agent, etc. for use.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3561780A JPS56131516A (en) | 1980-03-18 | 1980-03-18 | Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3561780A JPS56131516A (en) | 1980-03-18 | 1980-03-18 | Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56131516A true JPS56131516A (en) | 1981-10-15 |
JPS639492B2 JPS639492B2 (en) | 1988-02-29 |
Family
ID=12446802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3561780A Granted JPS56131516A (en) | 1980-03-18 | 1980-03-18 | Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56131516A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290235A (en) * | 1994-06-07 | 1995-12-20 | William H Waugh | Treatment of sickle cell disorders using aromatic urea compounds |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01305193A (en) * | 1988-06-01 | 1989-12-08 | Mitsubishi Electric Corp | Hydraulic pump device |
-
1980
- 1980-03-18 JP JP3561780A patent/JPS56131516A/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290235A (en) * | 1994-06-07 | 1995-12-20 | William H Waugh | Treatment of sickle cell disorders using aromatic urea compounds |
GB2290235B (en) * | 1994-06-07 | 1998-03-25 | William H Waugh | Treatment of sickle cell disorders using aromatic urea compounds |
Also Published As
Publication number | Publication date |
---|---|
JPS639492B2 (en) | 1988-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8767796A0 (en) | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION WITH CONTROLLED DELIVERY OF AN ACTIVE INGREDIENT | |
IE871981L (en) | Programmed release formulation. | |
NO970068L (en) | Inhaleringssammensetning | |
ES8105292A1 (en) | Urea derivatives for use in the treatment of fat metabolism disorders. | |
ATE424810T1 (en) | A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER | |
IE34746L (en) | 2-(n-allyl-n-arylamino)-imidazolines | |
ES8307496A1 (en) | Galenic preparation. | |
PH27446A (en) | Compound with gastric acid inhibitory effect | |
EP0647616A4 (en) | Zinc tranexamate compound. | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
JPS56131516A (en) | Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent | |
WO2002056867A3 (en) | Extended release pharmaceutical compositions containing beta-lactam antibiotics | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
JPS54132239A (en) | Anti-tumor agent | |
IE36780L (en) | Pharmaceutical preparations | |
GB1375806A (en) | ||
JPS5791914A (en) | Peptic unti-ulcer | |
KR950700063A (en) | Brofaromine as an agent for treating post-traumatic stress | |
JPS5746916A (en) | Antihyperlipemia | |
JPS5759809A (en) | Cardiotonic agent | |
PE20011042A1 (en) | USE OF GLUTAMINE FOR THE PREVENTION OF LATE ONSET DIARRHEA INDUCED BY IRINOTECAN | |
JPS5634624A (en) | Central nervous system depressant | |
EP0356192A3 (en) | Prevention & treatment of liver abscesses in animals | |
JPS57128625A (en) | Carcinostatic | |
JPS57126422A (en) | Stabilizing method of lysozyme pharmaceutical |